Circulating biomarkers for gliomas
M Westphal, K Lamszus - Nature Reviews Neurology, 2015 - nature.com
Currently, gliomas are diagnosed by neuroimaging, and refined diagnosis requires
resection or biopsy to obtain tumour tissue for histopathological classification and grading …
resection or biopsy to obtain tumour tissue for histopathological classification and grading …
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment
A Mafi, A Rahmati, Z Babaei Aghdam, R Salami… - Cellular & Molecular …, 2022 - Springer
Gliomas are the most lethal primary brain tumors in adults. These highly invasive tumors
have poor 5-year survival for patients. Gliomas are principally characterized by rapid …
have poor 5-year survival for patients. Gliomas are principally characterized by rapid …
A multimodal deep neural network for human breast cancer prognosis prediction by integrating multi-dimensional data
Breast cancer is a highly aggressive type of cancer with very low median survival. Accurate
prognosis prediction of breast cancer can spare a significant number of patients from …
prognosis prediction of breast cancer can spare a significant number of patients from …
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
Objective: To investigate the local immune status and its prognostic value in glioma.
Methods: A cohort of 297 glioma samples with whole genome microarray expression data …
Methods: A cohort of 297 glioma samples with whole genome microarray expression data …
[HTML][HTML] MicroRNAs as prognostic markers and therapeutic targets in gliomas
A Sufianov, S Begliarzade, T Ilyasova, Y Liang… - Non-coding RNA …, 2022 - Elsevier
Gliomas are invasive brain tumors characterized by high rates of recurrence and mortality.
Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its …
Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its …
The significant role of microRNAs in gliomas angiogenesis: a particular focus on molecular mechanisms and opportunities for clinical application
MicroRNAs (miRNAs) are non-coding RNAs with only 20–22 nucleic acids that inhibit gene
transcription and translation by binding to mRNA. MiRNAs have a diverse set of target genes …
transcription and translation by binding to mRNA. MiRNAs have a diverse set of target genes …
Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches
A Miranda, M Blanco-Prieto, J Sousa, A Pais… - International journal of …, 2017 - Elsevier
Glioblastoma multiforme (GBM) is the most common primary brain tumour, and the most
aggressive in nature. The prognosis for patients with GBM remains poor, with a median …
aggressive in nature. The prognosis for patients with GBM remains poor, with a median …
DC‐AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet
Purpose Pseudoprogression (PsP) occurs in 20–30% of patients with glioblastoma
multiforme (GBM) after receiving the standard treatment. PsP exhibits similarities in shape …
multiforme (GBM) after receiving the standard treatment. PsP exhibits similarities in shape …
Improve glioblastoma multiforme prognosis prediction by using feature selection and multiple kernel learning
Glioblastoma multiforme (GBM) is a highly aggressive type of brain cancer with very low
median survival. In order to predict the patient's prognosis, researchers have proposed rules …
median survival. In order to predict the patient's prognosis, researchers have proposed rules …
Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells
Anti-PD1 immunotherapy, as a single agent or in combination with standard
chemotherapies, has significantly improved the outcome of many patients with cancers …
chemotherapies, has significantly improved the outcome of many patients with cancers …